185 related articles for article (PubMed ID: 31985180)
1. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
Tikka T; Kavanagh K; Lowit A; Jiafeng P; Burns H; Nixon IJ; Paleri V; MacKenzie K
Clin Otolaryngol; 2020 May; 45(3):380-388. PubMed ID: 31985180
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of the Head and Neck Cancer Risk Calculator in identifying maxillofacial malignancies.
Simpson CD; Hennigan M; Morrison J
Br J Oral Maxillofac Surg; 2023 Jun; 61(5):356-361. PubMed ID: 37169617
[TBL] [Abstract][Full Text] [Related]
3. Head and neck cancer: A 6-year retrospective analysis and review of three common triaging systems.
Siddiqui Z; Hamid M; Caton N; Cheang PP
Clin Otolaryngol; 2023 Jul; 48(4):630-637. PubMed ID: 36977627
[TBL] [Abstract][Full Text] [Related]
4. Deprivation in relation to urgent suspicion of head and neck cancer referrals in Glasgow.
Zeitler M; Fingland P; Tikka T; Douglas CM; Montgomery J
Clin Otolaryngol; 2018 Jun; 43(3):861-867. PubMed ID: 29380938
[TBL] [Abstract][Full Text] [Related]
5. Refining the head and neck cancer referral guidelines: a two-centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Clin Otolaryngol; 2016 Feb; 41(1):66-75. PubMed ID: 26611658
[TBL] [Abstract][Full Text] [Related]
6. Refining the head and neck cancer referral guidelines: a two centre analysis of 4715 referrals.
Tikka T; Pracy P; Paleri V
Br J Oral Maxillofac Surg; 2016 Feb; 54(2):141-50. PubMed ID: 26857792
[TBL] [Abstract][Full Text] [Related]
7. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.
Kaddour H; Jama GM; Stagnell S; Kaddour S; Guner K; Kumar G
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1111-1115. PubMed ID: 34661717
[TBL] [Abstract][Full Text] [Related]
8. Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration.
Paleri V; Hardman J; Tikka T; Bradley P; Pracy P; Kerawala C
Head Neck; 2020 Jul; 42(7):1674-1680. PubMed ID: 32374942
[TBL] [Abstract][Full Text] [Related]
9. Two week wait referral criteria - heading in the right direction?
Gao C; Qin C; Freeman S; Oskooee N; Hughes J
J Laryngol Otol; 2019 Aug; 133(8):704-712. PubMed ID: 31370911
[TBL] [Abstract][Full Text] [Related]
10. Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service.
Li L; Tikka T; Morton C; Chan C; Hayois L; Henderson M; Hastie C; Lee L; Porteus L; Nixon I
J Laryngol Otol; 2023 Jul; 137(7):763-768. PubMed ID: 35995755
[TBL] [Abstract][Full Text] [Related]
11. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2.
Banerjee S; Voliotidis D; Parvin L; Rama SPK
J Laryngol Otol; 2021 Mar; 135(3):241-245. PubMed ID: 33648611
[TBL] [Abstract][Full Text] [Related]
12. Is the early identification and referral of suspected head and neck cancers by community pharmacists feasible? A qualitative interview study exploring the views of patients in North East England.
Bissett SM; Sturrock A; Carrozzo M; Lish R; Howe D; Mountain S; Nugent M; O'Hara J; Todd A; Wilkes S; Preshaw PM
Health Expect; 2023 Oct; 26(5):2089-2097. PubMed ID: 37458410
[TBL] [Abstract][Full Text] [Related]
13. Qualitative interview study exploring the early identification and referral of patients with suspected head and neck cancer by community pharmacists in England.
Sturrock A; Bissett SM; Carrozzo M; Lish R; Howe D; Mountain S; Nugent M; O'Hara J; Preshaw PM; Todd A; Wilkes S
BMJ Open; 2023 Mar; 13(3):e068607. PubMed ID: 36882255
[TBL] [Abstract][Full Text] [Related]
14. A comparison of community-based and hospital-based head and neck cancer screening campaigns: identifying high-risk individuals and early disease.
Harris MS; Phillips DR; Sayer JL; Moore MG
JAMA Otolaryngol Head Neck Surg; 2013 Jun; 139(6):568-73. PubMed ID: 23787414
[TBL] [Abstract][Full Text] [Related]
15. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
16. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
17. Challenges in diagnosing head and neck cancer in primary health care.
Nieminen M; Aro K; Mäkitie A; Harlin V; Kainulainen S; Jouhi L; Atula T
Ann Med; 2021 Dec; 53(1):26-33. PubMed ID: 32746635
[TBL] [Abstract][Full Text] [Related]
18. European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.
Foley RW; Maweni RM; Gorman L; Murphy K; Lundon DJ; Durkan G; Power R; O'Brien F; O'Malley KJ; Galvin DJ; Brendan Murphy T; William Watson R
BJU Int; 2016 Nov; 118(5):706-713. PubMed ID: 26833820
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank.
Mccarthy CE; Bonnet LJ; Marcus MW; Field JK
Int J Oncol; 2020 Nov; 57(5):1192-1202. PubMed ID: 33491742
[TBL] [Abstract][Full Text] [Related]
20. External validation of a cancer risk prediction model for suspected head and neck cancer referrals.
Tikka T; Paleri V; MacKenzie K
Clin Otolaryngol; 2018 Apr; 43(2):714-717. PubMed ID: 29054125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
